In the MAP sample, the mean age of the participants was 88.59 years, 56 were female (72.72%), 10 carried at least one APOE-ε4 allele (13%), and 47 individuals (61%) showed evidence of AD pathology at autopsy according to the NIA-Reagan AD criteria. The gene discussed is APOE; the disease is Alzheimer disease.